TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in total number of active joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: children's executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent's well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: microleakage at the cervical wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement of AEs/ASs with physician ranking
Endpoint domain: Adverse events/effects
Primary endpoint: Impact on treatment decision making
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: improvement in UAS7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: μ rhythm elbow flexion motor imagery eigenvalue E
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total mean morphine consumption during the first 24 postoperative hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS values at rest and with movement at six hours from block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time between block and the first opioid request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of TQC3564
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative medication cost reduction
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in antibiotic prescribing for cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: general satisfaction with the ICU's decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: emotional support provided
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Higher plasma adrenocorticotropic hormone (ACTH) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Behavioral withdrawal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Freedom from left ventricular assist device, heart transplant, or death at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Trismus reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Mortality Risk Score (MRS)
Endpoint domain: Adverse events/effects
Primary endpoint: Cervical vertigo symptoms and function evaluation scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSV (Peak Systolic Velocity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: serum alanine aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: body mass index standard deviation scores (BMI SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: functional connectivity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in number of cigarettes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Involvement in follow-up research
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived benefits of participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decision to participate based on child
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: salivary cortisol response to VR-TSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Neck pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy diet index score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDAI changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number needed to treat for PEC response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number needed to harm
Endpoint domain: Adverse events/effects
Primary endpoint: Likelihood to be helped or harmed
Endpoint domain: Adverse events/effects
Primary endpoint: annual heart failure readmission rate
Endpoint domain: Mortality/survival
Primary endpoint: Mean anatomical SS based on coronary CTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean functional SS based on coronary CTA and FFRCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cohen's κ comparing treatment recommendation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary intention healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Peak hip adduction moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recent HIV testing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in N‐NAIL score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in PROMs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: thromboembolic events (TE events)
Endpoint domain: Adverse events/effects
Primary endpoint: FV acceptance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS part III scores in the 'off' state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serious adverse event - hospitalisation due to Parkinson's disease rigidity
Endpoint domain: Adverse events/effects
Primary endpoint: Stability of haemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of hypotension episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients showing substantial clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Upper Extremity scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall success rate of radial artery cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: VAS scores for psychological stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lower extremity nontraumatic amputation
Endpoint domain: Adverse events/effects
Primary endpoint: Exclusively breastfeeding at one month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Exclusively breastfeeding at three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Any breastfeeding at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: desire to eat
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: test-retest reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KRT-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time within target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine-induced responses duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain score in early labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptions of partner's disinhibition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sex-related self-perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceptions of partner's friendliness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mazza GI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median SBTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post‐treatment MMSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labored breathing index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom burden in fibromyalgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in tissue thickness at the buccal aspect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in buccal defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proximal bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choice of intensive care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Match of telemedical diagnosis to on-site diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-inferiority of telemedical treatment compared to on-site treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Potential harm from telemedical therapeutic regimen
Endpoint domain: Adverse events/effects
Primary endpoint: peri-procedural adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: systolic and diastolic blood pressure decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cost of urgent/emergency DCC
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Virological outcomes (Ct values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transition to non-infectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pro-inflammatory cytokines IL-6 and IL-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: trough FEV1 at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rescue medication inhalations/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: clinically significant improvement in Transition Dyspnea Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: secondary TB cases detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in LELI score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction of pruritus
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: motor recovery measured by FMA-UE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unplanned readmission within 31 days after discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: IXT control score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of deviation reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walch‐Duplay score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acquisition of HIV
Endpoint domain: Mortality/survival
Primary endpoint: daily medication adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in high-sensitivity C-reactive protein (hsCRP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall rating of clinician communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: bacteraemia eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: clinical cure/improvement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reached for follow-up care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cost-effectiveness of combined treatment vs midurethral sling surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean reduction in urinary incontinence episodes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQoL improvement in total SLEQoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in DLQI scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adherence to exercise program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HR-HPV acquisition incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: enhance psychosocial functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduce severity of negative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total amount of fat oxidised
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dynamic resting-state markers of early antidepressant response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shorter paced QRS interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of death or HHF
Endpoint domain: Mortality/survival
Primary endpoint: declining 6 min walk distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median NRS score at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perioperative hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: engagement of right-frontoparietal network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: achievement of continuous abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Masticatory function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Duration of immersion in ice bath
Endpoint domain: Mortality/survival
Primary endpoint: Serologic responses to NY‐ESO‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in PD‐1 expression on Tregs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in PD‐L1 expression on CD14+ monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Radial artery occlusion persistent at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean angular deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 3D deviation at implant shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 3D deviation at implant apex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neuromuscular activity of pelvic floor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life related to pelvic floor functions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity to diagnose obstructive CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity to diagnose obstructive CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall accuracy to diagnose ACS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: toxicity prevention
Endpoint domain: Adverse events/effects
Primary endpoint: Abalakov jump time (ABKJT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abalakov jump height (ABKH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-squat test 1 repetition maximum (HST1RM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of disease associated with BCL2 and IL19 genotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum level of indoxyl sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of prepared surface area on phalangeal side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adjacent injury
Endpoint domain: Adverse events/effects
Primary endpoint: ExB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total failures
Endpoint domain: Mortality/survival
Primary endpoint: Diaphragmatic motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Orodental consultation request rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in Monthly Migraine Days (MMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in Migraine Headache Days (MHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in MIDAS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Follow-up rate (6-month Olerud and Molander Ankle Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous eye opening time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hypoxaemia
Endpoint domain: Adverse events/effects
Primary endpoint: scWAT inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Durable Progression-Free Survival (PFS) lasting greater than 24 weeks
Endpoint domain: Mortality/survival
Primary endpoint: affected UL movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abstinence at 7-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of successful intravenous catheter insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Satisfaction levels of patients and nurses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in mixed-meal tolerance test area under the glucose concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time in target glucose range on continuous glucose monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in absolute bodyweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of treatment-emergent adverse events (grade ≥3)
Endpoint domain: Adverse events/effects
Primary endpoint: Referral to Diabetes Prevention Program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Disability of the Arm, Shoulder, and Hand scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Higher rates of grade 3 vs grade 4 thrombocytopenia and neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: 20% or greater IOP reduction or 1 or more medication reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total power of HR variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VAS score at 5th minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score at 10th minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score at 15th minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation dead space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: median reduction from baseline to D2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants with >40% MFD reduction at D2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: JAK2V617F allele burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain score during and one hour after TRUS‐PBx
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative incidence of respiratory tract infection requiring medical intervention
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in olfactory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inter-segmental coordination patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP angle of the thigh-shank, thigh-trunk couplings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TNSS from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: respiratory patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: pain-related fear of movements
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction of fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes